Tango Therapeutics, Inc. (NASDAQ: TNGX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT TANGO THERAPEUTICS, INC.

Tango Therapeutics, Inc. (NASDAQ: TNGX)
Listen to this Section


$21.46
-0.0100 ( -0.05% ) 0.1K

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

Market Data


Open $21.46
Previous Close $21.47
Volume 0.1K
Market Cap $3.11B
Day Range $20.70 - $23.10
52 Week Range $2.96 - $28.41
Shares Outstanding 144.65M
Change % -0.05%
Net Change ▼ -0.0100
Insider Ownership -0.64%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2021
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -749,433.00

Date Type Amount Purchased Purchaser
2024-06-07 Sale -6250.00 Borisy Alexis
2024-06-07 Sale -6250.00 Rothenberg Mace
2024-06-07 Sale -63000.00 MVA Investors, LLC
2024-06-07 Sale -6250.00 Peters Malte
2024-05-03 Sale -75000.00 MVA Investors, LLC
2024-02-21 Sale -162500.00 Third Rock Ventures IV, L.P.
2024-02-08 Sale -4681.00 Weber Barbara
2024-02-08 Sale -1422.00 Barry Douglas
2024-02-08 Sale -1908.00 Beckman Daniella
2024-02-08 Sale -4288.00 Crystal Adam

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 63 Nov 04, 2025
4 Insider transactions 1 Nov 04, 2025
8-k 8K-related 13 Nov 04, 2025
4 Insider transactions 1 Oct 27, 2025
8-k 8K-related 16 Oct 24, 2025
8-k 8K-related 33 Oct 23, 2025
4 Insider transactions 1 Sep 29, 2025
4 Insider transactions 1 Sep 17, 2025
4 Insider transactions 1 Sep 09, 2025
4 Insider transactions 1 Aug 26, 2025

Latest News


× Before browsing our site, please accept our cookies policy